MARF Contributes $1 million to Mesothelioma Research

The Mesothelioma Applied Research Foundation announced today it has awarded an additional $1 million in research funding aimed at curing the asbestos-related cancer, mesothelioma. Meso is an aggressive, painful cancer of the linings of the lungs, abdomen, heart or testicles. After a very long latency, ten to fifty years, it can afflict anyone who has been exposed to asbestos, even in small amounts. For decades, it was mostly ignored in terms of medical interest or research funding. As a result, until recently there were no treatments that were better than doing nothing at all. [Press Release]

Money well spent. - ST